Stifel Starts Cardiovascular Systems (CSII) at Buy

Stifel analyst Matthew Blackman initiates coverage on Cardiovascular Systems (NASDAQ: CSII) with a Buy rating and a price target of $45.00.

The analyst likes the company's market leadership, differentiated portfolio and material US scale. He says the company is a re-acceleration/multiple re-rating story

For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.

Shares of Cardiovascular Systems closed at $37.60 yesterday.

You May Also Be Interested In

• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral